NYSE · TRLV
Trulieve Cannabis Corp. Subordinate Voting Shares
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for TRLV: Nov 05, 2026
Trulieve Cannabis Corp. Subordinate Voting Shares is expected to report earnings on 11/05/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $0.09.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.09 | $0.12 | $0.02 | 4 |
| Dec 2026 | $0.10 | $0.13 | $0.02 | 4 |
| Mar 2027 | $0.14 | $0.15 | $0.12 | 2 |
| Jun 2027 | $0.14 | $0.15 | $0.13 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat- Zacks · Oct 12, 7:55 AM EDTZacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisICU Medical, Neogen and Trulieve Cannabis offer distinct growth catalysts as medical products demand benefits from innovation, resilient procedures and evolving market opportunities.
- Zacks · Oct 9, 8:31 AM EDT3 Medical Product Stocks Positioned to Ride on the Industry TailwindsHere, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
- The Motley Fool · Oct 3, 7:20 AM EDT2 High-Octane Cannabis Stocks to Buy in October for Aggressive InvestorsThe two pot companies had higher second-quarter profit.
- The Motley Fool · Sep 22, 5:50 AM EDT2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026Trulieve and Cronos are both outperforming the S&P 500.
- MarketBeat · Aug 9, 7:03 AM EDTTrulieve Cannabis Q2 Earnings Call HighlightsTrulieve Cannabis (NYSE:TRLV) reported second-quarter revenue of $271 million, while outlining plans to expand in Georgia and Texas following changes in medical cannabis regulations and the company’s June listing on the New York Stock Exchange. The company said reported second-q
- The Motley Fool · Aug 6, 9:50 PM EDTVirginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.Limited-license states often favor established cannabis operators.
- Zacks · Aug 5, 8:55 AM EDTShould You Buy, Hold or Sell GTBIF Stock Post Q2 Earnings Release?Green Thumb tops Q2 earnings and sales estimates, but can regulatory catalysts, buybacks and expansion plans outweigh pricing pressure and fierce competition?
- The Motley Fool · Jul 10, 6:56 AM EDTBetter Cannabis Growth Stock: Trulieve or Vireo GrowthTrulieve is one of the few profitable cannabis companies.
- The Motley Fool · Jun 27, 12:11 PM EDTTrulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year136,811 shares sold directly by Trulieve's Chairman and CEO on June 26, 2026, for a transaction value of approximately $1.2 million based on a price of $8.76 per share.
- The Motley Fool · Jun 22, 9:29 AM EDTTrulieve's NYSE Listing Is Historic. But Is the Stock Still Worth Buying?Trulieve became the first U.S. cannabis stock on the NYSE.
- Zacks · Jun 18, 8:28 AM EDTGTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.
- The Motley Fool · Jun 16, 9:20 AM EDTThe Marijuana Industry Just Had a Massive MilestoneTrulieve Cannabis is a leading company in the marijuana market, and it's now trading on a major U.S. exchange.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Trulieve Cannabis Corp. Subordinate Voting Shares from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.